https://stock.noler.com/us/stock/prolor-biotech-inc https://stock.noler.com/us/stock/prolor-biotech-inc/accounts-payable-trade-current https://stock.noler.com/us/stock/prolor-biotech-inc/accrued-liabilities-current https://stock.noler.com/us/stock/prolor-biotech-inc/accumulated-depreciation https://stock.noler.com/us/stock/prolor-biotech-inc/acquisitions https://stock.noler.com/us/stock/prolor-biotech-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/prolor-biotech-inc/additional-paid-in-capital https://stock.noler.com/us/stock/prolor-biotech-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/prolor-biotech-inc/amended-reports-10-k https://stock.noler.com/us/stock/prolor-biotech-inc/amended-reports-10-q https://stock.noler.com/us/stock/prolor-biotech-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/prolor-biotech-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/prolor-biotech-inc/assets-noncurrent https://stock.noler.com/us/stock/prolor-biotech-inc/capital-expenditures https://stock.noler.com/us/stock/prolor-biotech-inc/cash-and-equivalents https://stock.noler.com/us/stock/prolor-biotech-inc/cash-flow-breakdown https://stock.noler.com/us/stock/prolor-biotech-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/prolor-biotech-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/prolor-biotech-inc/common-stock-no-par-value https://stock.noler.com/us/stock/prolor-biotech-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/prolor-biotech-inc/common-stock-value https://stock.noler.com/us/stock/prolor-biotech-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/prolor-biotech-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/prolor-biotech-inc/costs-and-expenses https://stock.noler.com/us/stock/prolor-biotech-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/prolor-biotech-inc/current-assets https://stock.noler.com/us/stock/prolor-biotech-inc/current-liabilities https://stock.noler.com/us/stock/prolor-biotech-inc/debt-repaid https://stock.noler.com/us/stock/prolor-biotech-inc/deferred-compensation-arrangement-with-individual-allocated-share-based-compensation-expense https://stock.noler.com/us/stock/prolor-biotech-inc/deposits-assets-current https://stock.noler.com/us/stock/prolor-biotech-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/prolor-biotech-inc/depreciation https://stock.noler.com/us/stock/prolor-biotech-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/prolor-biotech-inc/due-to-related-parties-current https://stock.noler.com/us/stock/prolor-biotech-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/prolor-biotech-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/prolor-biotech-inc/financing-cash-flow https://stock.noler.com/us/stock/prolor-biotech-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/prolor-biotech-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/prolor-biotech-inc/form-d-stocks https://stock.noler.com/us/stock/prolor-biotech-inc/general-and-administrative-expense https://stock.noler.com/us/stock/prolor-biotech-inc/grants-receivable https://stock.noler.com/us/stock/prolor-biotech-inc/grants-receivable-current https://stock.noler.com/us/stock/prolor-biotech-inc/income-taxes-paid https://stock.noler.com/us/stock/prolor-biotech-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/prolor-biotech-inc/increase-decrease-in-accounts-receivable-and-other-operating-assets https://stock.noler.com/us/stock/prolor-biotech-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/prolor-biotech-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/prolor-biotech-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/prolor-biotech-inc/insider-transactions-preferred https://stock.noler.com/us/stock/prolor-biotech-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/prolor-biotech-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/prolor-biotech-inc/insider-transactions-warrants https://stock.noler.com/us/stock/prolor-biotech-inc/interest-expense https://stock.noler.com/us/stock/prolor-biotech-inc/interest-income-expense-net https://stock.noler.com/us/stock/prolor-biotech-inc/interest-paid https://stock.noler.com/us/stock/prolor-biotech-inc/investing-cash-flow https://stock.noler.com/us/stock/prolor-biotech-inc/investment-income-interest https://stock.noler.com/us/stock/prolor-biotech-inc/lease-and-rental-expense https://stock.noler.com/us/stock/prolor-biotech-inc/loans-assumed https://stock.noler.com/us/stock/prolor-biotech-inc/net-change-in-cash https://stock.noler.com/us/stock/prolor-biotech-inc/net-income https://stock.noler.com/us/stock/prolor-biotech-inc/new-accounting-pronouncement-or-change-in-accounting-principle-cumulative-effect-of-change-on-equity-or-net-assets https://stock.noler.com/us/stock/prolor-biotech-inc/noncash-or-part-noncash-acquisition-net-nonmonetary-assets-acquired-liabilities-assumed https://stock.noler.com/us/stock/prolor-biotech-inc/noncash-or-part-noncash-acquisition-other-assets-acquired https://stock.noler.com/us/stock/prolor-biotech-inc/operating-cash-flow https://stock.noler.com/us/stock/prolor-biotech-inc/operating-income https://stock.noler.com/us/stock/prolor-biotech-inc/operating-lease-payments-due https://stock.noler.com/us/stock/prolor-biotech-inc/operating-leases-future-minimum-payments-next-rolling-twelve-months https://stock.noler.com/us/stock/prolor-biotech-inc/other-current-assets https://stock.noler.com/us/stock/prolor-biotech-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/prolor-biotech-inc/other-income https://stock.noler.com/us/stock/prolor-biotech-inc/paid-in-capital-other https://stock.noler.com/us/stock/prolor-biotech-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/prolor-biotech-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/prolor-biotech-inc/preferred-shares-facts https://stock.noler.com/us/stock/prolor-biotech-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/prolor-biotech-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/prolor-biotech-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/prolor-biotech-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/prolor-biotech-inc/preferred-stock-value https://stock.noler.com/us/stock/prolor-biotech-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/prolor-biotech-inc/prepaid-expense-current https://stock.noler.com/us/stock/prolor-biotech-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/prolor-biotech-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/prolor-biotech-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/prolor-biotech-inc/proceeds-from-repayments-of-short-term-debt https://stock.noler.com/us/stock/prolor-biotech-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/prolor-biotech-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/prolor-biotech-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/prolor-biotech-inc/professional-fees https://stock.noler.com/us/stock/prolor-biotech-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/prolor-biotech-inc/property-plant-equipment https://stock.noler.com/us/stock/prolor-biotech-inc/public-float https://stock.noler.com/us/stock/prolor-biotech-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/prolor-biotech-inc/repayments-of-debt https://stock.noler.com/us/stock/prolor-biotech-inc/research-and-development https://stock.noler.com/us/stock/prolor-biotech-inc/research-and-development-arrangement-contract-to-perform-for-others-costs-incurred-gross https://stock.noler.com/us/stock/prolor-biotech-inc/research-and-development-arrangement-with-federal-government-customer-funding-to-offset-costs-incurred https://stock.noler.com/us/stock/prolor-biotech-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/prolor-biotech-inc/research-and-development-in-process https://stock.noler.com/us/stock/prolor-biotech-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/prolor-biotech-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/prolor-biotech-inc/revenue https://stock.noler.com/us/stock/prolor-biotech-inc/salaries-wages-and-officers-compensation https://stock.noler.com/us/stock/prolor-biotech-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/prolor-biotech-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-10-k https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-10-q https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-10ksb https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-10qsb https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-15-12b https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-25-nse https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-425 https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-8-k https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-ars https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-certnys https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-def-14a https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-defa14a https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-defm14a https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-ntn-10q https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-prem14a https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-prer14a https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-regdex https://stock.noler.com/us/stock/prolor-biotech-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/prolor-biotech-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/prolor-biotech-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/prolor-biotech-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/prolor-biotech-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/prolor-biotech-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/prolor-biotech-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/prolor-biotech-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/prolor-biotech-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/prolor-biotech-inc/severance-costs https://stock.noler.com/us/stock/prolor-biotech-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/prolor-biotech-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/prolor-biotech-inc/share-price https://stock.noler.com/us/stock/prolor-biotech-inc/shareholders-equity https://stock.noler.com/us/stock/prolor-biotech-inc/shares-authorized https://stock.noler.com/us/stock/prolor-biotech-inc/shares-issued https://stock.noler.com/us/stock/prolor-biotech-inc/shares-issued-value-issued-for-services https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/prolor-biotech-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/prolor-biotech-inc/stock-based-compensation https://stock.noler.com/us/stock/prolor-biotech-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/prolor-biotech-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/prolor-biotech-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/prolor-biotech-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/prolor-biotech-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/prolor-biotech-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/prolor-biotech-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/prolor-biotech-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/prolor-biotech-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/prolor-biotech-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/prolor-biotech-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/prolor-biotech-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/prolor-biotech-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/prolor-biotech-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/prolor-biotech-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/prolor-biotech-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/prolor-biotech-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/prolor-biotech-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/prolor-biotech-inc/total-assets https://stock.noler.com/us/stock/prolor-biotech-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/prolor-biotech-inc/value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/prolor-biotech-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/prolor-biotech-inc/weighted-average-number-of-share-outstanding-basic-and-diluted